Multicomponent DNA Nanomachines for Amplification-Free Viral RNA Detection.
Valeria V Solyanikova1, Daria A Gorbenko1, Valeriya V Zryacheva2
1DNA-Nanosensoric Diagnostic Lab., ITMO University, 9 Lomonosova St., 191002 St. Petersburg, Russia.
International Journal of Molecular Sciences
|May 7, 2025
Summary
Researchers developed novel DNA nanomachines for rapid viral detection. These cost-effective tools offer sensitive identification of respiratory viruses like HPIV and RSV without complex equipment.
Area of Science:
- Molecular Biology
- Nanotechnology
- Virology
Background:
- Viral infections pose significant global health challenges, necessitating accurate and rapid diagnostic methods.
- Current gold-standard methods like quantitative reverse transcription PCR (RT-qPCR) have limitations including high costs and complex requirements.
- Alternative, cost-effective diagnostic approaches are crucial for widespread application, including point-of-care settings.
Purpose of the Study:
- To develop and characterize novel multicomponent DNA nanomachines for sensitive and specific detection of viral nucleic acids.
- To engineer DNA nanomachines capable of recognizing and signaling the presence of specific RNA viruses, including human parainfluenza virus type 3 (HPIV) and respiratory syncytial virus (RSV).
- To evaluate the potential of these DNA nanomachines as an alternative to traditional diagnostic techniques for viral infections.
Main Methods:
- Design and synthesis of multicomponent DNA nanomachines featuring RNA-binding arms and a catalytic core.
- Utilizing a fluorescent substrate that generates a signal upon interaction with target nucleic acids.
- Engineering specific variants for the detection of HPIV and RSV RNA.
Main Results:
- The developed DNA nanomachines demonstrated catalytic proficiency towards a fluorescent substrate, generating a signal in the presence of target nucleic acids.
- The engineered nanomachine design incorporates RNA-binding arms for efficient recognition and unwinding of RNA structures.
- The study successfully tailored variants for detecting specific RNA viruses, indicating feasibility for clinical diagnostics.
Conclusions:
- DNA nanomachines offer a promising amplification-free approach for nucleic acid detection, bypassing the need for enzymes and costly equipment.
- These nanomachines present a feasible, cost-effective, and sensitive alternative for diagnosing viral infections, suitable for both laboratory and point-of-care use.
- The developed technology holds significant potential for advancing infectious disease management through reliable RNA virus identification.
